Literature DB >> 23572316

SPECT vs CT: CT is not the first line test for the diagnosis and prognosis of stable coronary artery disease.

Zachary J Trzaska1, Mylan C Cohen.   

Abstract

Entities:  

Mesh:

Year:  2013        PMID: 23572316     DOI: 10.1007/s12350-013-9709-z

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  25 in total

1.  The economic consequences of available diagnostic and prognostic strategies for the evaluation of stable angina patients: an observational assessment of the value of precatheterization ischemia. Economics of Noninvasive Diagnosis (END) Multicenter Study Group.

Authors:  L J Shaw; R Hachamovitch; D S Berman; T H Marwick; M S Lauer; G V Heller; A E Iskandrian; K L Kesler; M I Travin; H C Lewin; R C Hendel; S Borges-Neto; D D Miller
Journal:  J Am Coll Cardiol       Date:  1999-03       Impact factor: 24.094

2.  Cost-effectiveness of coronary CT angiography versus myocardial perfusion SPECT for evaluation of patients with chest pain and no known coronary artery disease.

Authors:  James K Min; Amanda Gilmore; Matthew J Budoff; Daniel S Berman; Ken O'Day
Journal:  Radiology       Date:  2010-03       Impact factor: 11.105

3.  Nuclear cardiology will remain the "gatekeeper" over CT angiography.

Authors:  Rory Hachamovitch; Marcelo F Di Carli
Journal:  J Nucl Cardiol       Date:  2007 Sep-Oct       Impact factor: 5.952

4.  Radiation risk from coronary artery disease imaging: how do different diagnostic tests compare?

Authors:  Andrew J Einstein
Journal:  Heart       Date:  2008-12       Impact factor: 5.994

5.  Incremental prognostic value of myocardial perfusion single photon emission computed tomography in patients with diabetes mellitus.

Authors:  X Kang; D S Berman; H C Lewin; I Cohen; J D Friedman; G Germano; R Hachamovitch; L J Shaw
Journal:  Am Heart J       Date:  1999-12       Impact factor: 4.749

6.  Value of stress myocardial perfusion single photon emission computed tomography in patients with normal resting electrocardiograms: an evaluation of incremental prognostic value and cost-effectiveness.

Authors:  Rory Hachamovitch; Daniel S Berman; Hosen Kiat; Ishac Cohen; John D Friedman; Leslee J Shaw
Journal:  Circulation       Date:  2002-02-19       Impact factor: 29.690

7.  Reduced isotope dose with rapid SPECT MPI imaging: initial experience with a CZT SPECT camera.

Authors:  W Lane Duvall; Lori B Croft; Tapan Godiwala; Eric Ginsberg; Titus George; Milena J Henzlova
Journal:  J Nucl Cardiol       Date:  2010-11-12       Impact factor: 5.952

8.  Normal stress-only versus standard stress/rest myocardial perfusion imaging: similar patient mortality with reduced radiation exposure.

Authors:  Su Min Chang; Faisal Nabi; Jiaqiong Xu; Umara Raza; John J Mahmarian
Journal:  J Am Coll Cardiol       Date:  2009-11-13       Impact factor: 24.094

9.  Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy.

Authors:  Leslee J Shaw; Daniel S Berman; David J Maron; G B John Mancini; Sean W Hayes; Pamela M Hartigan; William S Weintraub; Robert A O'Rourke; Marcin Dada; John A Spertus; Bernard R Chaitman; John Friedman; Piotr Slomka; Gary V Heller; Guido Germano; Gilbert Gosselin; Peter Berger; William J Kostuk; Ronald G Schwartz; Merill Knudtson; Emir Veledar; Eric R Bates; Benjamin McCallister; Koon K Teo; William E Boden
Journal:  Circulation       Date:  2008-02-11       Impact factor: 29.690

10.  Diagnostic value of SPECT, PET and PET/CT in the diagnosis of coronary artery disease: A systematic review.

Authors:  M Al Moudi; Z Sun; N Lenzo
Journal:  Biomed Imaging Interv J       Date:  2011-04-01
View more
  1 in total

1.  Evidence for myocardial CT perfusion imaging in the diagnosis of hemodynamically significant coronary artery disease.

Authors:  Zhonghua Sun
Journal:  Cardiovasc Diagn Ther       Date:  2015-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.